Occupational exposure to benzene and risk of non‐ Hodgkin lymphoma in an extended follow‐up of two population‐based prospective cohorts of Chinese men and women
Year: 2024
Type: article
Study design: Observational Study
Abstract: The carcinogenicity of benzene was reevaluated by the International Agency for Research on Cancer in 2017, with the Working Group reaffirming positive yet inconclusive associations with non‐Hodgkin lymphoma (NHL). To extend our previous observation of a significant exposure‐response for cumulative occupational benzene exposure and NHL risk among Chinese women in a population‐based cohort in Shanghai, we extended follow‐up of this cohort and pooled the data with a similarly designed population‐based cohort of men in Shanghai. Cumulative exposure estimates were derived for 134,449 participants in the pooled analysis by combining ordinal job‐exposure matrix intensity ratings with quantitative benzene measurements from an inspection database of Shanghai factories. Associations between benzene exposure metrics and NHL ( n = 363 cases including multiple myeloma [MM]) were assessed using Cox proportional hazard models. Ever occupational exposure to benzene in the pooled population was associated with NHL risk (HR = 1.5, 95% CI = 1.2–2.0), and exposure‐response relationships were observed for increasing duration ( p trend = .003) and cumulative exposure ( p trend = .003). Associations with ever exposure, duration, and cumulative exposure were similar for NHL with and without MM in the case definition, including lifetime cumulative exposures in the highest quartile (HR = 1.6, 95% CI = 1.1–2.4 with MM included; HR = 1.7, 95% CI = 1.1–2.7 with MM excluded). An elevated risk of the chronic lymphocytic leukemia subtype was suggested in the pooled analyses (HR for ever vs. never exposure = 2.3, 95% CI = 0.9–5.6). These observations provide additional support for a plausible association between occupational benzene exposure and risk of NHL.
Source: International Journal of Cancer
DOI: 10.1002/ijc.35095
Institutions: Inova Health System, Inova Fairfax Hospital, Vanderbilt University, Vanderbilt University Medical Center, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Utrecht University, National Heart, Lung, and Blood Institute, National Heart, Lung, and Blood Institute Division of Intramural Research, Information Management Services, Shanghai Jiao Tong University, Shanghai Cancer Institute
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,840
Funder: National Cancer Institute
Awards: G2788466971, G6766166885
OpenAlex ID: W4402131372
